Regulatory Hurdles in European Drug Discovery

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This research service provides detailed analysis of the Regulatory Hurdles in European Drug Discovery. The research service is a powerpoint format (approximately 82 slides) focuses on providing an overview of the current European pharmaceutical landscape, as well as challenges and strategies for achieving success in this highly competitive market.

Table of Contents

Regulatory Hurdles in European Drug Discovery, Regulatory Hurdles in European Drug DiscoveryOverviewOverviewResearch Scope & MethodologyResearch Scope & MethodologyKey Definitions and AbbreviationsKey Definitions and AbbreviationsIntroductionIntroductionOverview of EC DirectivesOverview of EC DirectivesEuropean Authorisation ProcedureEuropean Authorisation ProcedureRegulatory PolicyRegulatory PolicyState Members of the European UnionState Members of the European UnionApplicants and Other European CountriesApplicants and Other European CountriesRegulatory ChallengesRegulatory ChallengesRegulatory Hurdles in Austrian Drug DiscoveryRegulatory Hurdles in Austrian Drug DiscoveryRegulatory Hurdles in Belgium Drug DiscoveryRegulatory Hurdles in Belgium Drug DiscoveryRegulatory Hurdles in Czech Republic Drug DiscoveryRegulatory Hurdles in Czech Republic Drug DiscoveryRegulatory Hurdles in Danish Drug DiscoveryRegulatory Hurdles in Danish Drug DiscoveryRegulatory Hurdles in Finnish Drug DiscoveryRegulatory Hurdles in Finnish Drug DiscoveryRegulatory Hurdles in French Drug DiscoveryRegulatory Hurdles in French Drug DiscoveryRegulatory Hurdles in German Drug DiscoveryRegulatory Hurdles in German Drug DiscoveryRegulatory Hurdles in Greek Drug DiscoveryRegulatory Hurdles in Greek Drug DiscoveryRegulatory Hurdles in Hungarian Drug DiscoveryRegulatory Hurdles in Hungarian Drug DiscoveryRegulatory Hurdles in Italian Drug DiscoveryRegulatory Hurdles in Italian Drug DiscoveryRegulatory Hurdles in Polish Drug DiscoveryRegulatory Hurdles in Polish Drug DiscoveryRegulatory Hurdles in Portuguese Drug DiscoveryRegulatory Hurdles in Portuguese Drug DiscoveryRegulatory Hurdles in Slovakian Drug DiscoveryRegulatory Hurdles in Slovakian Drug DiscoveryRegulatory Hurdles in Spanish Drug DiscoveryRegulatory Hurdles in Spanish Drug DiscoveryRegulatory Hurdles in Swedish Drug DiscoveryRegulatory Hurdles in Swedish Drug DiscoveryRegulatory Hurdles in the United Kingdom Drug DiscoveryRegulatory Hurdles in the United Kingdom Drug DiscoveryConclusionThe FutureDecision Support DatabasesDecision Support Databases




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.